Panacur AquaSol

Country: European Union

Language: Croatian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

fenbendazol

Available from:

Intervet International BV

ATC code:

QP52AC13

INN (International Name):

fenbendazole

Therapeutic group:

Pigs; Chicken

Therapeutic area:

Антгельминтики, , Бензимидазолы i srodnih tvari, фенбендазола

Therapeutic indications:

Za liječenje probavnog sustava hookworms svinja zaraženo:аскарида АЧС (odrasla osoba, crijeva i migracija larvi stadija);Oesophagostomum CSE. (odrasli stadij);власоглавы суис (odrasli stadij). Za liječenje probavnog sustava нематодозах pilića, zaražene:Ascaridia Galli l (L5 i odrasle);Heterakis gallinarum (Л5 i odrasle);Capillaria CSE. (Л5 i odrasle osobe).

Product summary:

Revision: 6

Authorization status:

odobren

Authorization date:

2011-12-09

Patient Information leaflet

                                B. UPUTA O VMP
14
UPUTA O VMP:
PANACUR AQUASOL
200 MG/ML SUSPENZIJA ZA PRIMJENU U VODI ZA PIĆE ZA SVINJE I KOKOŠI
1.
NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE U PROMET I
NOSITELJA ODOBRENJA ZA PROIZVODNJU ODGOVORNOG ZA PUŠTANJE
PROIZVODNE SERIJE, AKO JE RAZLIČITO
Nositelj odobrenja za stavljanje u promet:
Intervet International BV
Wim de Körverstraat 35
5831 AN Boxmeer
Nizozemska
Nositelj odobrenja za proizvodnju odgovoran za puštanje proizvodne
serije:
Intervet Productions SA
Rue de Lyons
27460 Igoville
Francuska
2.
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA
Panacur AquaSol 200 mg/ml suspenzija za primjenu u vodi za piće za
svinje i kokoši
Fenbendazol
3.
NAVOĐENJE DJELATNE(IH) TVARI I DRUGIH SASTOJAKA
Veterinarsko medicinski proizvod je bijela do bezbojna suspenzija za
primjenu u vodi za piće koja
sadrži 200 mg/ml, fenbendazol i 20 mg/ml benzil alkohola (E1519)
4.
INDIKACIJE
Svinje:
Za tretiranje i kontrolu gastro-intestinalnih nematoda u svinja
infestiranih s:
_- _
_Ascaris suum_
(odrasli stadij, crijevni i fazu migracije ličinke)
_- _
_Oesophagostomum spp._
(odrasli stadiji)
-
_Trichuris suis_
(odrasli stadiji).
Kokoši:
Za tretiranje gastro-intestinalnih nematoda u kokoši infestiranih s:
_-_
_ _
_Ascaridia galli _
(L5 i odrasli stadiji)
_ _
_-_
_ _
_Heterakis gallinarum_
(L5 i odrasli stadiji)
_ _
_-_
_ _
_Capillaria _
spp
_. _
(L5 i odrasli stadiji)
_ _
5.
KONTRAINDIKACIJE
Nema
15
6.
NUSPOJAVE
Nisu poznate.
Ako zamijetite ozbiljne nuspojave ili druge nuspojave koje nisu
opisane u uputi o VMP, molimo
javite veterinaru.
7.
CILJNE VRSTE ŽIVOTINJA
Svinje i kokoši
8.
DOZIRANJE ZA SVAKU CILJNU VRSTU ŽIVOTINJA, NAČIN I PUT(EVI)
PRIMJENE
Primjena u vodi za piće.
Da bi osigurali pravilnu dozu treba, što je moguće točnije utvrditi
tjelesnu težinu te provjeriti točnost
uređaja za doziranje.
Prije nego dopustimo životinjama pristup vodi s VMP, sustav napajanja
treba isprazniti, ako je
moguće, te ga potom napuniti s vodom koja sadrži VMP kako bi se
osigurala točnost doziranja. Ovaj
postup
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                DODATAK I
SAŽETAK OPISA SVOJSTAVA
1
1.
NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA
Panacur AquaSol 200 mg/ml suspenzija za primjenu u vodi za piće za
svinje i kokoši
2.
KVALITATIVNI I KVANTITATIVNI SASTAV
1 ml sadrži:
DJELATNA TVAR
:
Fenbendazol
200 mg
POMOĆNE TVARI:
Benzilni alkohol (E1519)
20 mg
Za potpuni popis pomoćnih tvari vidi odjeljak 6.1.
3.
FARMACEUTSKI OBLIK
Bijela do bezbojna suspenzija za primjenu u vodi za piće.
Čestice suspenzije su veličine submikrona.
4.
KLINIČKE POJEDINOSTI
4.1
CILJNE VRSTE ŽIVOTINJA
Svinje i kokoši
4.2
INDIKACIJE ZA PRIMJENU, NAVESTI CILJNE VRSTE ŽIVOTINJA
Svinje:
Tretman i kontrola gastrointestinalnih nematoda u svinja infestiranih
s:
-
_Ascaris suum_
(odrasli stadij, crijevna i migracijska ličinka),
-
_Oesophagostomum spp._
(odrasli stadiji),
-
_Trichuris suis_
(odrasli stadiji).
Kokoši:
Tretman gastrointestinalnih nematoda u kokoši infestiranih s:
-
_Ascaridia galli_
(L5 i odrasli stadiji),
-
_Heterakis gallinarum _
(L5 i odrasli stadiji),
_ _
-
_Capillaria _
spp.
_ _
( L5 i odrasli stadiji).
_ _
4.3
KONTRAINDIKACIJE
Nema
4.4
POSEBNA UPOZORENJA ZA SVAKU CILJNU VRSTU
Otpornost parazita na određenu klasu anthelmintika može se razviti
nakon česte primjene nekog
anthelmintika te klase.
4.5
POSEBNE MJERE PREDOSTROŽNOST ZA PRIMJENU
2
Posebne mjere predostrožnost za primjenu na životinjama
U nedostatku podataka, terapiju kokoši mlađih od 3 tjedna treba
bazirati na procjeni koristi/rizik
odgovornog veterinara.
Posebne mjere opreza koje mora poduzeti osoba koja primjenjuje
veterinarsko-medicinski proizvod na
životinjama
Ovaj veterinarsko medicinski proizvod može biti otrovan za ljude
nakon konzumiranja hrane. Embrio
toksični simptomi ne mogu se isključiti. Trudnice trebaju biti vrlo
oprezne prilikom rukovanja ovim
proizvodom.
Izbjegavajte kontakt s kožom, očima i sluznicama. Osobe s poznatom
preosjetljivošću na fenbendazol
trebaju izbjegavati kontakt s proizvodom.
Treba koristiti osobnu zaštitnu opremu koja sadrži zaštitne
rukavice dok rukujete s veter
                                
                                Read the complete document
                                
                            

Documents in other languages

Patient Information leaflet Patient Information leaflet Bulgarian 26-04-2018
Summary of Product characteristics Summary of Product characteristics Bulgarian 26-04-2018
Public Assessment Report Public Assessment Report Bulgarian 26-04-2018
Patient Information leaflet Patient Information leaflet Spanish 26-04-2018
Public Assessment Report Public Assessment Report Spanish 26-04-2018
Patient Information leaflet Patient Information leaflet Czech 26-04-2018
Public Assessment Report Public Assessment Report Czech 26-04-2018
Patient Information leaflet Patient Information leaflet Danish 26-04-2018
Public Assessment Report Public Assessment Report Danish 26-04-2018
Patient Information leaflet Patient Information leaflet German 26-04-2018
Public Assessment Report Public Assessment Report German 26-04-2018
Patient Information leaflet Patient Information leaflet Estonian 26-04-2018
Public Assessment Report Public Assessment Report Estonian 26-04-2018
Patient Information leaflet Patient Information leaflet Greek 26-04-2018
Public Assessment Report Public Assessment Report Greek 26-04-2018
Patient Information leaflet Patient Information leaflet English 26-04-2018
Public Assessment Report Public Assessment Report English 26-04-2018
Patient Information leaflet Patient Information leaflet French 26-04-2018
Public Assessment Report Public Assessment Report French 26-04-2018
Patient Information leaflet Patient Information leaflet Italian 26-04-2018
Public Assessment Report Public Assessment Report Italian 26-04-2018
Patient Information leaflet Patient Information leaflet Latvian 26-04-2018
Public Assessment Report Public Assessment Report Latvian 26-04-2018
Patient Information leaflet Patient Information leaflet Lithuanian 26-04-2018
Summary of Product characteristics Summary of Product characteristics Lithuanian 26-04-2018
Public Assessment Report Public Assessment Report Lithuanian 26-04-2018
Patient Information leaflet Patient Information leaflet Hungarian 26-04-2018
Summary of Product characteristics Summary of Product characteristics Hungarian 26-04-2018
Public Assessment Report Public Assessment Report Hungarian 26-04-2018
Patient Information leaflet Patient Information leaflet Maltese 26-04-2018
Public Assessment Report Public Assessment Report Maltese 26-04-2018
Patient Information leaflet Patient Information leaflet Dutch 26-04-2018
Public Assessment Report Public Assessment Report Dutch 26-04-2018
Patient Information leaflet Patient Information leaflet Polish 26-04-2018
Public Assessment Report Public Assessment Report Polish 26-04-2018
Patient Information leaflet Patient Information leaflet Portuguese 26-04-2018
Summary of Product characteristics Summary of Product characteristics Portuguese 26-04-2018
Public Assessment Report Public Assessment Report Portuguese 26-04-2018
Patient Information leaflet Patient Information leaflet Romanian 26-04-2018
Public Assessment Report Public Assessment Report Romanian 26-04-2018
Patient Information leaflet Patient Information leaflet Slovak 26-04-2018
Public Assessment Report Public Assessment Report Slovak 26-04-2018
Patient Information leaflet Patient Information leaflet Slovenian 26-04-2018
Summary of Product characteristics Summary of Product characteristics Slovenian 26-04-2018
Public Assessment Report Public Assessment Report Slovenian 26-04-2018
Patient Information leaflet Patient Information leaflet Finnish 26-04-2018
Public Assessment Report Public Assessment Report Finnish 26-04-2018
Patient Information leaflet Patient Information leaflet Swedish 26-04-2018
Public Assessment Report Public Assessment Report Swedish 26-04-2018
Patient Information leaflet Patient Information leaflet Norwegian 26-04-2018
Summary of Product characteristics Summary of Product characteristics Norwegian 26-04-2018
Patient Information leaflet Patient Information leaflet Icelandic 26-04-2018
Summary of Product characteristics Summary of Product characteristics Icelandic 26-04-2018

Search alerts related to this product